LA TERRE FAVORISE
Food supplement declared in France, declaration No 2021-8-302, decision dated 4 August 2021
LA TERRE FAVORISE (EDLI) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Rosa canina 226 mg per day, Salvia officinalis 170 mg per day, Harpagophytum procumbens 136 mg per day, Olea europaea 102 mg per day, Boswellia serrata 82 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- EDLI
- Food business operator placing the product on the market
- EDLI
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Tablet
- Daily dose
- 1-2
- Directions for use
- prendre 1 à 2 comprimés par jour avec un verre d'eau
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women, Ulcer (stomach or duodenum)
- Objectives stated by the manufacturer (these are not authorised claims)
- Digestion
Declaration 313074, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Rosa canina L. | Fruit | Autre extrait sec | 226 mg |
| Salvia officinalis L. | Feuille | Extrait sec hydroalcoolique | 170 mg |
| Harpagophytum procumbens | Racine | Extrait sec hydroalcoolique | 136 mg |
| Olea europaea L. | Fruit | Autre extrait sec | 102 mg |
| Boswellia serrata Roxb. ex Colebr. | Résine | Extrait sec hydroalcoolique | 82 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Alpha-cyclodextrine | not declared |
| Gamma-cyclodextrine | not declared |
Additives
E468, E460, E551, E464, E470b
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Ne pas dépasser la dose recommandé Ne pas utiliser en cas d'ulcère gastrique ou duodénal ou de calculs biliaires. A tenir hors de portée des jeunes enfants Pour les femmes enceintes ou allaitantes, se reporter à l'avis d'un médecin.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Salvia officinalis L.
Read the warning, when it applies and the studies cited
SAGE - SALVIA OFFICINALIS - Buccal
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
SAGE -SALVIA OFFICINALIS Oral
Cautions and warnings
Condition of application: Carminative, Diaphoretic, Antihidrotic, Antigalactagogue.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).
Sources cited by Health Canada (3)
- Bradley PR, editor. 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drug-Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Do not use if you have a seizure disorder such as epilepsy (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).
Sources cited by Health Canada (3)
- Bradley PR, editor. 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drug-Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- Harpagophytum procumbens
Read the warning, when it applies and the studies cited
DEVIL'S CLAW - HARPAGOPHYTUM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
- Olea europaea L.
Read the warning, when it applies and the studies cited
OLIVE LEAF - OLEA EUROPAEA
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you pregnant or breastfeeding (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other diuretics (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Known adverse reactions
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : EDLI
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “LA TERRE FAVORISE (EDLI): composition and regulation”, https://compoatlas.com/en/supplements/products/313074-la-terre-favorise, updated 15 November 2026.